Keywords: Novartis, Lucentis, Diabetic macular edema, DME, UK, NICE

UK's NICE draft guidance backs NHS use of Lucentis in DME

Article | 05 October 2012

Print This

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE), in new draft guidance issued this morning (October 5) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in